BioRestorative Therapies, Inc. (FRA:9OF)

BioRestorative Therapies Revenue

BioRestorative Therapies had revenue of $11.80K USD in the quarter ending September 30, 2025, a decrease of -94.95%. This brings the company's revenue in the last twelve months to $383.40K, up 1.70% year-over-year. In the year 2024, BioRestorative Therapies had annual revenue of $401.00K with 175.03% growth.

• Revenue (ttm): $383.40K
• Revenue Growth: +1.70%
• P/S Ratio: 24.30
• Revenue / Employee: $34.85K
• Employees: 11
• Market Cap: 7.94M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	401.00K	255.20K	175.03%
Dec 31, 2023	145.80K	26.00K	21.70%
Dec 31, 2022	119.80K	73.80K	160.43%
Dec 31, 2021	46.00K	-31.00K	-40.26%
Dec 31, 2020	77.00K	-53.00K	-40.77%
Dec 31, 2019	130.00K	19.00K	17.12%
Dec 31, 2018	111.00K	30.00K	37.04%
Dec 31, 2017	81.00K	44.65K	122.80%
Dec 31, 2016	36.36K	-592.56K	-94.22%
Dec 31, 2015	628.92K	212.92K	51.18%
Dec 31, 2014	416.00K	414.32K	24,661.67%
Dec 31, 2013	1.68K	-13.91K	-89.22%
Dec 31, 2012	15.59K	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-